Post-approval studies (Phase 4)Study completedNCT01753297
What this trial is testing
Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.
Who this might be right for
Prostate Cancer
Ipsen 226